-
Revenue
$-2.24M
Net Income
-
Gross Margin
-
Op. Margin
$-867.58K
Free Cash Flow
| Breakdown | Q2 2026 (Dec 31, 2025) |
Q1 2026 (Sep 30, 2025) |
Q4 2025 (Jun 30, 2025) |
Q3 2025 (Mar 31, 2025) |
Q2 2025 (Dec 31, 2024) |
Q1 2025 (Sep 30, 2024) |
|---|---|---|---|---|---|---|
| Total Revenue | - | - | - | - | - | - |
| Revenue Growth % (YoY) | nan% | nan% | nan% | nan% | nan% | nan% |
| Operating Expenses | $421.79K | $369.62K | $742.10K | $257.02K | $280.56K | $370.47K |
| Research & Development | - | - | $250.00 | - | $75.00 | - |
| Selling General & Admin | $421.79K | $369.62K | $741.85K | $257.02K | $280.48K | $370.47K |
| Operating Income | $-421.79K | $-369.62K | $-742.10K | $-257.02K | $-280.56K | $-370.47K |
| Operating Margin % | nan% | nan% | nan% | nan% | nan% | nan% |
| Interest Expense | $83.29K | $77.67K | $200.03K | $98.16K | $111.14K | $54.09K |
| Other Income/Expense | $-84.07K | $-75.08K | $-176.66K | $-111.04K | $-101.22K | $697.08K |
| Income Before Tax | $-505.86K | $-444.70K | - | - | - | - |
| Income Tax Expense | - | - | - | - | - | - |
| Net Income | $-505.86K | $-444.70K | $-918.76K | $-368.06K | $-381.78K | $326.62K |
| Net Margin % | nan% | nan% | nan% | nan% | nan% | nan% |
| Basic EPS | nan | nan | nan | nan | nan | 0.00 |
| Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Shares Outstanding | 425.9M | 397.1M | - | - | - | 229.0M |
| Diluted Shares Outstanding | - | 397.1M | 14.5M | 271.0M | 251.6M | 259.2M |
| Breakdown | Q2 2026 (Dec 31, 2025) |
Q1 2026 (Sep 30, 2025) |
Q4 2025 (Jun 30, 2025) |
Q3 2025 (Mar 31, 2025) |
Q2 2025 (Dec 31, 2024) |
Q1 2025 (Sep 30, 2024) |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | - | - | - | - | - | $8.10K |
| Total Current Assets | $27.63K | $8.61K | $67.64K | - | $6.66K | $8.10K |
| Total Assets | $27.63K | $8.61K | $67.64K | $22.21K | $6.66K | $8.10K |
| Total Current Liabilities | $6.41M | $6.05M | $5.91M | $5.31M | $4.99M | $4.71M |
| Common Stock | $45.39K | $41.76K | $36.86K | $28.21K | $26.55K | $24.25K |
| Retained Earnings | $-65.04M | $-64.53M | $-64.09M | $-63.17M | $-62.80M | $-62.42M |
| Total Stockholders Equity | $-6.39M | $-6.04M | $-5.84M | $-5.29M | $-4.99M | $-4.70M |
| Total Liabilities & Equity | $27.63K | $8.61K | $67.64K | $22.21K | $6.66K | $8.10K |
| Breakdown | Q2 2026 (Dec 31, 2025) |
Q1 2026 (Sep 30, 2025) |
Q4 2025 (Jun 30, 2025) |
Q3 2025 (Mar 31, 2025) |
Q2 2025 (Dec 31, 2024) |
Q1 2025 (Sep 30, 2024) |
|---|---|---|---|---|---|---|
| Net Income | $-950.56K | $-444.70K | $-918.76K | $-368.06K | $-381.78K | $326.62K |
| Stock-based Compensation | $260.95K | $112.40K | - | $75.77K | $75.77K | $75.77K |
| Change in Payables | - | $10.00K | - | - | - | - |
| Operating Cash Flow | $-292.69K | $-163.71K | $-157.29K | $-253.89K | $-218.25K | $-110.60K |
| Financing Cash Flow | $256.43K | $106.55K | $195.22K | $267.65K | $216.45K | $110.25K |
SEC Filing Format - Data shown as it appears in the Q2 2026 (10-Q) filing
Period ended: Dec 31, 2025
Condensed Consolidated Statements of Operations
| Description | Dec 31, 2025 | Dec 31, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | - | - | - | - |
| Operating Expenses | $421.79K | $280.56K | $791.41K | $651.02K |
| Research & Development | - | $75.00 | - | $75.00 |
| Selling General & Admin | $421.79K | $280.48K | $791.41K | $650.95K |
| Operating Income | $-421.79K | $-280.56K | $-791.41K | $-651.02K |
| Interest Expense | $83.29K | $111.14K | $160.97K | $165.23K |
| Other Income/Expense | $-84.07K | $-101.22K | $-159.15K | $595.86K |
| Income Before Tax | $-505.86K | $-381.78K | $-950.56K | $-55.16K |
| Income Tax Expense | - | - | - | - |
| Net Income | $-505.86K | $-381.78K | $-950.56K | $-55.16K |
| Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Shares Outstanding | $425.91M | $251.59M | $411.51M | $240.31M |
Condensed Consolidated Balance Sheets
| Description | Dec 31, 2025 | Jun 30, 2025 |
|---|---|---|
| Total Current Assets | $27.63K | $67.64K |
| Total Assets | $27.63K | $67.64K |
| Total Current Liabilities | $6.41M | $5.91M |
| Common Stock | $45.39K | $36.86K |
| Retained Earnings | $-65.04M | $-64.09M |
| Total Stockholders Equity | $-6.39M | $-5.84M |
| Total Liabilities & Equity | $27.63K | $67.64K |
Condensed Consolidated Statements of Cash Flows
| Description | Dec 31, 2025 | Dec 31, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $-505.86K | $-381.78K | $-950.56K | $-55.16K |
| Stock-based Compensation | - | - | $260.95K | $75.77K |
| Operating Cash Flow | - | - | $-292.69K | $-218.25K |
| Financing Cash Flow | - | - | $256.43K | $216.45K |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.
Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.